Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07312162 · ClinicalTrials.gov registry record
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
A clinical trial of Hepatocellular Carcinoma, sponsored by University of Southern California.
- Recruiting
- Registry status
- 730
- Enrollment target
- 1
- Study location
NCT07312162 is a study of Hepatocellular Carcinoma that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 730 participants, above the 252-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (190% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07312162, a study of Hepatocellular Carcinoma, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- 730 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates barriers to early detection of liver cancer.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 730 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07312162
The ClinicalTrials.gov registry entry for NCT07312162 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 730 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 252-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (190% higher). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07312162 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07312162 about?
NCT07312162 is a clinical study titled "Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots". This study evaluates barriers to early detection of liver cancer.
What is the current status of trial NCT07312162?
This trial is currently recruiting. The enrollment target is 730 participants. The study started on 2022-01-01. Estimated completion is 2027-12-31.
What conditions does trial NCT07312162 study?
This clinical trial studies the following conditions: Hepatocellular Carcinoma.
What interventions are being tested in trial NCT07312162?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07312162?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07312162 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatocellular Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Molecular Basis of Pediatric Liver Cancer
RECRUITING
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
-
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.